LSTM led partnership awarded £1.5 million for NTD drug development

(Liverpool School of Tropical Medicine) An LSTM led partnership has been awarded nearly £1.5 million from the Medical Research Council (MRC) for the pre-clinical development of a candidate drug to treat onchocerciasis and lymphatic filariasis, by targeting the bacterial symbiont Wolbachia.

Comments